Efficacy and Safety of Praziquantel in Preschool-Aged Children in an Area Co-Endemic for Schistosoma mansoni and S. haematobium

PLoS Neglected Tropical Diseases

Volumn 6, Issue 12, 2012, Pages

  Coulibaly, Jean T ^a,b,c,d   N'Gbesso, Yve K ^e   Knopp, Stefanie ^a,b   Keiser, Jennifer ^a,b   N'Goran, Eliézer K ^c,d   Utzinger, Jürg ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

^d CENTRE SUISSE DE RECHERCHES SCIENTIFIQUES EN CÔTE D'IVOIRE   (Côte d’Ivoire)

^e Centre de Santé Rural d'Azaguié   (Côte d’Ivoire)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL;

ABDOMINAL PAIN; ARTICLE; CHILD; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FECES ANALYSIS; FEMALE; FEVER; FOLLOW UP; HEADACHE; HUMAN; IMMUNOCHEMISTRY; INCIDENCE; INFANT; INFLAMMATION; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRESCHOOL CHILD; PREVALENCE; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS MANSONI; TABLET; URINALYSIS; VOMITING;

ADMINISTRATION, ORAL; ANIMALS; ANTHELMINTICS; CHEMOPREVENTION; CHILD, PRESCHOOL; COTE D'IVOIRE; DRUG TOXICITY; FECES; FEMALE; HUMANS; INFANT; MALE; PRAZIQUANTEL; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS MANSONI; TREATMENT OUTCOME; URINE;

EID: 84872032993     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001917     Document Type: Article

References (49)

1. King CH, Dickman K, Tisch DJ, (2005) Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365: 1561-1569.
2. Gryseels B, Polman K, Clerinx J, Kestens L, (2006) Human schistosomiasis. Lancet 368: 1106-1118.
3. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J, (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411-425.
4. Utzinger J, Raso G, Brooker S, de Savigny D, Tanner M, et al. (2009) Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology 136: 1859-1874.
5. Gray DJ, Ross AG, Li YS, McManus DP, (2011) Diagnosis and management of schistosomiasis. BMJ 342: d2651.
6. Stephenson LS, Latham MC, Kurz KM, Miller D, Kinoti SN, et al. (1985) Urinary iron loss and physical fitness of Kenyan children with urinary schistosomiasis. Am J Trop Med Hyg 34: 322-330.
7. Stoltzfus RJ, Albonico M, Tielsch JM, Chwaya HM, Savioli L, (1997) Linear growth retardation in Zanzibari school children. J Nutr 127: 1099-1105.
8. Jukes MC, Nokes CA, Alcock KJ, Lambo JK, Kihamia C, et al. (2002) Heavy schistosomiasis associated with poor short-term memory and slower reaction times in Tanzanian schoolchildren. Trop Med Int Health 7: 104-117.
9. Bhargava A, Jukes M, Lambo J, Kihamia CM, Lorri W, et al. (2003) Anthelmintic treatment improves the hemoglobin and serum ferritin concentrations of Tanzanian schoolchildren. Food Nutr Bull 24: 332-342.
10. WHO (2002) Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. WHO Tech Rep Ser 912: 1-57.
11. Fenwick A, Savioli L, Engels D, Bergquist NR, Todd MH, (2003) Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol 19: 509-515.
12. Utzinger J, Keiser J, (2004) Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin Pharmacother 5: 263-285.
13. Doenhoff MJ, Cioli D, Utzinger J, (2008) Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 21: 659-667.
14. WHO (2012) Schistosomiasis: population requiring preventive chemotherapy and number of people treated in 2010. Wkly Epidemiol Rec 87: 37-44.
15. Savioli L, Gabrielli AF, Montresor A, Chitsulo L, Engels D, (2009) Schistosomiasis control in Africa: 8 years after World Health Assembly Resolution 54.19. Parasitology 136: 1677-1681.
16. Jordan P, Webbe G, Sturrock RF (1993) Human schistosomiasis (eds Jordan P, Webbe G, Sturrock RF) CAB International, Wallingford, UK.
17. Stothard JR, Sousa-Figueiredo JC, Betson M, Green HK, Seto EYW, et al. (2011) Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children. Parasitology 138: 1593-1606.
18. Keiser J, Ingram K, Utzinger J, (2011) Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control. Parasitology 138: 1620-1632.
19. Mafiana CF, Ekpo UF, Ojo DA, (2003) Urinary schistosomiasis in preschool children in settlements around Oyan Reservoir in Ogun State, Nigeria: implications for control. Trop Med Int Health 8: 78-82.
20. Bosompem KM, Bentum IA, Otchere J, Anyan WK, Brown CA, et al. (2004) Infant schistosomiasis in Ghana: a survey in an irrigation community. Trop Med Int Health 9: 917-922.
21. Odogwu SE, Ramamurthy NK, Kabatereine NB, Kazibwe F, Tukahebwa E, et al. (2006) Schistosoma mansoni in infants (aged <3 years) along the Ugandan shoreline of Lake Victoria. Ann Trop Med Parasitol 100: 315-326.
22. Sousa-Figueiredo JC, Basàñez MG, Mgeni AF, Khamis IS, Rollinson D, et al. (2008) A parasitological survey, in rural Zanzibar, of pre-school children and their mothers for urinary schistosomiasis, soil-transmitted helminthiases and malaria, with observations on the prevalence of anaemia. Ann Trop Med Parasitol 102: 679-692.
23. Garba A, Barkire N, Djibo A, Lamine MS, Sofo B, et al. (2010) Schistosomiasis in infants and preschool-aged children: infection in a single Schistosoma haematobium and a mixed S. haematobium-S. mansoni foci of Niger. Acta Trop 115: 212-219.
24. Sousa-Figueiredo JC, Pleasant J, Day M, Betson M, Rollinson D, et al. (2010) Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole. Int Health 2: 103-113.
25. Sousa-Figueiredo JC, Day M, Betson M, Kabatereine NB, Stothard JR, (2010) An inclusive dose pole for treatment of schistosomiasis in infants and preschool children with praziquantel. Trans R Soc Trop Med Hyg 104: 740-742.
26. Dabo A, Badawi HM, Bary B, Doumbo OK, (2011) Urinary schistosomiasis among preschool-aged children in Sahelian rural communities in Mali. Parasit Vectors 4: 21.
27. Ekpo UF, Oluwole AS, Abe EM, Etta HE, Olamiju F, et al. (2012) Schistosomiasis in infants and pre-school-aged children in sub-Saharan Africa: implication for control. Parasitology 139: 835-841.
28. Navaratnam AMD, Sousa-Figueiredo JC, Stothard JR, Kabatereine NB, Fenwick A, et al. (2012) Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety. Trans R Soc Trop Med Hyg 106: 400-407.
29. Sousa-Figueiredo JC, Betson M, Atuhaire A, Arinaitwe M, Navaratnam AMD, et al. (2012) Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children. PLoS Negl Trop Dis 6: e1864.
30. WHO (2010) Report of a meeting to review the results of studies on the treatment of schistosomiasis in preschool-aged children. Geneva: World Health Organization, 1-23.
31. Coulibaly JT, Knopp S, N'Guessan NA, Silué KD, Fürst T, et al. (2011) Accuracy of urine circulating cathodic antigen (CCA) test for Schistosoma mansoni diagnosis in different settings of Côte d'Ivoire. PLoS Negl Trop Dis 5: e1384.
32. Coulibaly JT, Fürst T, Silué KD, Knopp S, Hauri D, et al. (2012) Intestinal parasitic infections in schoolchildren in different settings of Côte d'Ivoire: effect of diagnostic approach and implications for control. Parasit Vectors 5: 135.
33. N'Guessan NA, Acka CA, Utzinger J, N'Goran EK, (2006) Identification des régions à haut risque de schistosomoses en Côte d'Ivoire. Bull Soc Pathol Exot 100: 119-123 (in French).
34. Lemeshow S, Hosmer DW Jr, Klar J, Lwanga SK (1990) Adequacy of sample size in health studies. Chichester: Wiley, 233 p.
35. Katz N, Chaves A, Pellegrino J, (1972) A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop São Paulo 14: 397-400.
36. Utzinger J, N'Goran EK, Caffrey CR, Keiser J, (2011) From innovation to application: social-ecological context, diagnostics, drugs and integrated control of schistosomiasis. Acta Trop 120 (Suppl 1):: S121-137.
37. Keiser J, N'Guessan NA, Adoubryn KD, Silué KD, Vounatsou P, et al. (2010) Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. Clin Infect Dis 50: 1205-1213.
38. Stothard JR, Gabrielli AF, (2007) Schistosomiasis in African infants and preschool children: to treat or not to treat? Trends Parasitol 23: 83-86.
39. Sousa-Figueiredo JC, Betson M, Stothard JR, (2012) Treatment of schistosomiasis in African infants and preschool-aged children: downward extension and biometric optimization of the current praziquantel dose pole. Int Health 4: 95-102.
40. Mutapi F, Rujeni N, Bourke C, Mitchell K, Appleby L, et al. (2011) Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel. PLoS Negl Trop Dis 5: e1143.
41. Utzinger J, Booth M, N'Goran EK, Müller I, Tanner M, et al. (2001) Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel. Parasitology 122: 537-544.
42. Nibbeling HA, van Lieshout L, Deelder AM, (1998) Levels of circulating soluble egg antigen in urine of individuals infected with Schistosoma mansoni before and after treatment with praziquantel. Trans R Soc Trop Med Hyg 92: 675-677.
43. Legesse M, Erko B, (2007) Field-based evaluation of a reagent strip test for diagnosis of Schistosoma mansoni by detecting circulating cathodic antigen in urine before and after chemotherapy. Trans R Soc Trop Med Hyg 101: 668-673.
44. Scherrer AU, Sjöberg MK, Allangba A, Traoré M, Lohourignon LK, et al. (2009) Sequential analysis of helminth egg output in human stool samples following albendazole and praziquantel administration. Acta Trop 109: 226-231.
45. N'Goran EK, Gnaka HN, Tanner M, Utzinger J, (2003) Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire. Ann Trop Med Parasitol 97: 37-51.
46. Raso G, N'Goran EK, Toty A, Luginbühl A, Adjoua CA, et al. (2004) Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire. Trans R Soc Trop Med Hyg 98: 18-27.
47. Olliaro PL, Vaillant MT, Belizario VJ, Lwambo NJ, Ouldabdallahi M, et al. (2011) A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg/kg vs. 60 mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil. PLoS Negl Trop Dis 5: e1165.
48. Namwanje H, Kabatereine NB, Olsen A, (2011) The acceptability and safety of praziquantel alone and in combination with mebendazole in the treatment of Schistosoma mansoni and soil-transmitted helminthiasis in children aged 1-4 years in Uganda. Parasitology 138: 1586-1592.
49. Johansen MV, Sacko M, Vennervald BJ, Kabatereine NB, (2007) Leave children untreated and sustain inequity!. Trends Parasitol 23: 568-569.